BioXcel Therapeutics (BTAI) Current Taxes (2020 - 2026)
BioXcel Therapeutics (BTAI) posted quarterly Current Taxes of $46000.0 for Q1 2026, down 29.23% year-over-year from $65000.0 in Q1 2025, and up 43.75% quarter-over-quarter from $32000.0 in Q4 2025.
BioXcel Therapeutics (BTAI) Current Taxes (2020 - 2026) Analysis & Trends
BioXcel Therapeutics' Current Taxes history runs 7 years deep, the most recent figure standing at $46000.0 for Q1 2026.
- In Q1 2026, Current Taxes fell 29.23% year-over-year to $46000.0; the TTM figure through Mar 2026 stood at $46000.0 (down 29.23% YoY), while the FY2025 annual figure was $32000.0, down 64.84% from the prior year.
- Current Taxes for Q1 2026 stood at $46000.0, up from $32000.0 in the prior quarter.
- The five-year high for Current Taxes was $529000.0 in Q3 2022, with the low at $32000.0 in Q4 2025.
- The 5-year median for Current Taxes is $103000.0 (2025), against an average of $147705.9.
- The sharpest annual moves came in 2022 and 2023: Current Taxes jumped 165.83% in 2022, then plunged 74.86% in 2023.
- BioXcel Therapeutics' Current Taxes stood at $82000.0 in 2022, then soared by 41.46% to $116000.0 in 2023, then declined by 21.55% to $91000.0 in 2024, then slumped by 64.84% to $32000.0 in 2025, then jumped by 43.75% to $46000.0 in 2026.
- Business Quant data shows BTAI's Current Taxes at $46000.0 in Q1 2026, $32000.0 in Q4 2025, and $103000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | -355.54 Mn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 138.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 739.89 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 46.00 Mn |
| 10 | BioXcel Therapeutics | 24.29 Mn | 24.29 Mn | 160,000.00 | 40,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 40,000.00 |
| Mar 31, 2026 | 46,000.00 |
| Dec 31, 2025 | 32,000.00 |
| Sep 30, 2025 | 103,000.00 |
| Jun 30, 2025 | 108,000.00 |
| Mar 31, 2025 | 65,000.00 |
| Dec 31, 2024 | 91,000.00 |
| Sep 30, 2024 | 71,000.00 |
| Jun 30, 2024 | 70,000.00 |
| Mar 31, 2024 | 85,000.00 |
| Dec 31, 2023 | 116,000.00 |
| Sep 30, 2023 | 133,000.00 |
| Jun 30, 2023 | 144,000.00 |
| Mar 31, 2023 | 212,000.00 |
| Dec 31, 2022 | 82,000.00 |
| Sep 30, 2022 | 529,000.00 |
| Jun 30, 2022 | 258,000.00 |
| Mar 31, 2022 | 366,000.00 |
| Dec 31, 2021 | 302,000.00 |
| Sep 30, 2021 | 199,000.00 |